News | February 24, 2012

Emergency Department Admissions Down for Heart Attack, Up for Stroke

David Seaberg, M.D., CPE, FACEP, president of the American College of Emergency Physicians (ACEP)


February 24, 2012 — A new report released today by HealthGrades found that from 2008 to 2010, emergency admissions for heart attack decreased slightly (1.7 percent) for Medicare patients, but admissions for stroke increased by 2.2 percent. Heart attack and stroke were among the conditions with the highest mortality rates, with nearly one in 10 heart attack patients dying, and nearly one in 10 stroke patients (9.24 percent) dying, after admission to the hospital.

David Seaberg, M.D., CPE, FACEP, president of the American College of Emergency Physicians (ACEP), said the information is useful for tracking mortality rates for heart attack and stroke patients who are admitted to the hospital, although the report itself is a measure of inpatient hospital care, not emergency care.

"The information about heart attack and stroke admissions is not surprising," said Seaberg. "Emergency physicians encourage all adults, especially seniors, to know the warning signs of stroke and heart attack. It's important to err on the side of caution, call 911 and get to the nearest emergency department as soon as possible if you think you're having a stroke or heart attack."

According to the report, nearly 61 percent of hospital admissions among seniors begin in the emergency department, more than any other age group.

The new data are being released in HealthGrades "2012 Emergency Medicine in American Hospitals" report, in which they rank the nation's top hospitals.

Seaberg added that the emergency department is the safety net of the entire health care system and the first stop for millions entering a hospital each year in search of care.

For more information: www.acep.org


Related Content

News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 18, 2025 — (Newswise) It’s often mistaken for a heart attack, but Takotsubo cardiomyopathy — previously known as ...

Home August 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 20, 2025 — A major international study published in Atherosclerosis* has found that routinely testing for ...

Home August 20, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 4, 2025 — Marea Therapeutics, Inc., a clinical-stage biotechnology company that develops next-generation medicines ...

Home August 04, 2025
Home
News | Cardiovascular Clinical Studies

July 16, 2025 — Medtronic has announced that the first patient has been enrolled in the PEripheral Onyx Liquid Embolic ...

Home July 22, 2025
Home
News | Cardiovascular Clinical Studies

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

Home June 11, 2025
Home
News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
Subscribe Now